SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001038133-21-000031
Filing Date
2021-06-10
Accepted
2021-06-09 18:34:17
Documents
13
Period of Report
2021-06-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K hska-20210608.htm   iXBRL 8-K 46870
2 EX-10.1 ex101wilsonemploymentagree.htm EX-10.1 284415
  Complete submission text file 0001038133-21-000031.txt   528662

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hska-20210608.xsd EX-101.SCH 1906
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hska-20210608_lab.xml EX-101.LAB 23970
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hska-20210608_pre.xml EX-101.PRE 12644
6 EXTRACTED XBRL INSTANCE DOCUMENT hska-20210608_htm.xml XML 19054
Mailing Address 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538
Business Address 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538 9704937272
HESKA CORP (Filer) CIK: 0001038133 (see all company filings)

IRS No.: 770192527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22427 | Film No.: 211006333
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences